Loading...
Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy
BACKGROUND: Retreatment with ipilimumab has been shown to re-establish disease control in some patients with disease progression. Here, we report the efficacy and safety of retreatment with ipilimumab 3 mg kg(−1) among patients participating in an expanded access programme in Italy. METHODS: Patient...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3974075/ https://ncbi.nlm.nih.gov/pubmed/24619072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.126 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|